Most bought healthcare stocks in Q4 2024
See which Healthcare stocks institutional investors increased the most in Q4 2024, measured as net growth in reported share positions from Q3 2024 into Q4 2024. Notable additions at the top of this list include AVANTOR INC (AVTR), CVS HEALTH CORP (CVS), BAXTER INTERNATIONAL INC (BAX), DR. REDDY'S LABORATORIES-ADR (RDY). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| AVTR | AVANTOR INC | 27,001,813 | $172.29M | 1 | 3 | 2 | 2 | 6 |
| CVS | CVS HEALTH CORP | 12,680,093 | -$918.15M | 1 | 3 | 7 | 3 | 11 |
| BAX | BAXTER INTERNATIONAL INC | 9,706,337 | -$417.48M | 1 | 4 | 3 | 0 | 9 |
| RDY | DR. REDDY'S LABORATORIES-ADR | 7,967,009 | -$6.23M | 0 | 3 | 0 | 0 | 3 |
| HUM | HUMANA INC | 6,178,167 | $778.06M | 2 | 2 | 2 | 1 | 6 |
| ZOM | ZOMEDICA CORP | 4,120,642 | $490.78K | 1 | 0 | 0 | 0 | 2 |
| TVTX | TRAVERE THERAPEUTICS INC | 3,436,425 | $66.29M | 1 | 1 | 0 | 0 | 2 |
| TEM | TEMPUS AI INC | 3,141,487 | $51.74M | 0 | 1 | 0 | 0 | 1 |
| LLY | ELI LILLY & CO | 2,816,324 | $1.91B | 2 | 5 | 3 | 1 | 12 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 2,637,961 | $9.17M | 0 | 1 | 0 | 0 | 1 |
| CERS | CERUS CORP | 2,446,830 | $11.41K | 0 | 1 | 1 | 0 | 2 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 2,427,043 | $212.90M | 1 | 2 | 5 | 1 | 10 |
| OCGN | OCUGEN INC | 2,087,632 | $1.68M | 1 | 0 | 0 | 0 | 1 |
| LCTX | LINEAGE CELL THERAPEUTICS IN | 2,085,972 | $968.81K | 0 | 1 | 0 | 0 | 1 |
| COO | COOPER COS INC/THE | 2,014,762 | $182.49M | 1 | 1 | 2 | 0 | 4 |
| ABSI | ABSCI CORP | 1,928,314 | -$2.55M | 0 | 1 | 0 | 0 | 1 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1,645,236 | $306.77M | 1 | 1 | 1 | 0 | 3 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,618,207 | -$3.41M | 0 | 3 | 0 | 1 | 3 |
| TXG | 10X GENOMICS INC-CLASS A | 1,580,667 | -$65.67M | 1 | 1 | 0 | 0 | 2 |
| GERN | GERON CORP | 1,452,700 | $5.14M | 1 | 0 | 0 | 0 | 1 |
| EDIT | EDITAS MEDICINE INC | 1,451,049 | $1.84M | 1 | 0 | 0 | 0 | 1 |
| VRTX | VERTEX PHARMACEUTICALS INC | 1,419,762 | $453.95M | 1 | 2 | 3 | 1 | 6 |
| EVH | EVOLENT HEALTH INC - A | 1,415,300 | -$52.02M | 0 | 1 | 0 | 0 | 1 |
| LYEL | LYELL IMMUNOPHARMA INC | 1,414,746 | $759.36K | 0 | 1 | 0 | 0 | 1 |
| SENS | SENSEONICS HOLDINGS INC | 1,376,020 | $720.21K | 1 | 0 | 0 | 0 | 1 |
| FOLD | AMICUS THERAPEUTICS INC | 1,339,316 | $11.65M | 0 | 1 | 0 | 0 | 1 |
| WRBY | WARBY PARKER INC-CLASS A | 1,336,592 | $113.65M | 0 | 3 | 1 | 0 | 4 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 1,280,300 | $3.40M | 0 | 1 | 0 | 0 | 1 |
| ELV | ELEVANCE HEALTH INC | 1,249,728 | -$653.39M | 1 | 4 | 4 | 1 | 11 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 1,221,808 | $67.89M | 0 | 2 | 3 | 0 | 5 |
| GILD | GILEAD SCIENCES INC | 1,185,581 | $441.50M | 0 | 3 | 4 | 0 | 8 |
| NVST | ENVISTA HOLDINGS CORP | 1,179,913 | $16.25M | 1 | 1 | 2 | 0 | 4 |
| ZTS | ZOETIS INC | 1,119,198 | -$156.32M | 0 | 4 | 3 | 0 | 10 |
| GSK | GSK PLC-SPON ADR | 970,367 | -$473.02M | 0 | 4 | 2 | 0 | 6 |
| BSX | BOSTON SCIENTIFIC CORP | 950,449 | $92.47M | 0 | 3 | 1 | 1 | 5 |
| SOLV | SOLVENTUM CORP | 936,928 | $60.22M | 0 | 2 | 2 | 2 | 4 |
| BNTX | BIONTECH SE-ADR | 894,556 | $101.71M | 0 | 1 | 0 | 0 | 1 |
| LEGN | LEGEND BIOTECH CORP-ADR | 890,000 | $28.67M | 0 | 1 | 0 | 0 | 1 |
| TSHA | TAYSHA GENE THERAPIES INC | 878,448 | $1.52M | 1 | 0 | 0 | 0 | 1 |
| RLAY | RELAY THERAPEUTICS INC | 878,095 | $1.63M | 0 | 1 | 0 | 0 | 1 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | 869,949 | -$213.37K | 0 | 1 | 0 | 0 | 1 |
| TMO | THERMO FISHER SCIENTIFIC INC | 852,622 | $16.58M | 2 | 4 | 5 | 0 | 13 |
| ACAD | ACADIA PHARMACEUTICALS INC | 823,333 | $16.31M | 0 | 1 | 0 | 0 | 1 |
| DHR | DANAHER CORP | 794,543 | -$149.10M | 0 | 3 | 3 | 2 | 10 |
| TDOC | TELADOC HEALTH INC | 763,265 | $6.50M | 0 | 1 | 0 | 0 | 1 |
| IPSC | CENTURY THERAPEUTICS INC | 714,685 | $380.09K | 0 | 1 | 0 | 0 | 1 |
| ILMN | ILLUMINA INC | 702,129 | $32.60M | 3 | 1 | 2 | 0 | 6 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 680,965 | $9.00M | 1 | 0 | 0 | 0 | 1 |
| DCGO | DOCGO INC | 662,490 | $2.86M | 2 | 1 | 0 | 0 | 3 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | 650,200 | $830.53K | 0 | 1 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q4 2024
What are the most bought Healthcare stocks in Q4 2024?
The most bought healthcare stocks in Q4 2024 are those with the largest increase in reported share counts across tracked institutional investors compared to Q3 2024, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q4 2024?
Among the managers we track, net additions were largest in companies such as AVANTOR INC (AVTR), CVS HEALTH CORP (CVS), BAXTER INTERNATIONAL INC (BAX), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q3 2024).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.